“All other Medicare rules apply”—that’s the information you’ll find in the fine print of Medicare’s Clinical Trial Policy (also known as NCD 310.1). National and Local Coverage Determinations (NCDs and LCDs) are important Medicare coverage policies that fall into this category, and items frequently required by protocols—such as EKGs, lipid panels, and imaging tests—have such determinations. This webinar will provide tips on how to interpret and comply with these policies, and will provide examples of common challenges in this area of coverage analysis.

Register for this FREE webinar here!

While it may seem obvious that budget creation, negotiation and payment collection are interconnected, institutions can be met with payment delays and unrecognized revenue if their strategies for these steps do not capture the points of connection from the start. In this webinar, PFS Clinical’s experts will provide tips and tricks to help research organizations create a cohesive budget, negotiation, and payment collection process.

Join Liz Christianson, Client Engagement Manager and Amanda Miller, Training Manager at PFS Clinical, to learn strategies for budgeting, negotiating, and collecting clinical trial payments. 

Sign up here!

As the business climate in health care continues to transform, entities engaged in clinical research are evaluating the costs and benefits of participating in clinical research. Is it just about the bottom line in the financial statements? Join PFS Clinical and Bio-Optronics for a webinar to learn about ideas and tips to ensure the mission of the research department/ institute is aligned with the parent organization, and opportunities to communicate value that may not show up in your “P&L Statement”. 

Register for this free webinar here!

As research funds are becoming increasingly competitive, a frequent question asked is, “How much should we pay investigators for their work on a clinical trial and what methodology should be used?”. While the question may seem straightforward, it is far more complex and potentially volatile under the surface. The amount and the method by which you use to pay investigators can play a big role in the success, or lack thereof, of your site.

Join PFS Clinical’s Director of Site Strategy, David B. Russell, for a free, educational webinar on PI Compensation. During this webinar, David will discuss the regulation considerations when setting compensation amounts, the pros and cons of different PI compensation models, and investigator agreement considerations.

Specific areas that will be covered include:

• Pros and cons of different PI payment models
• Investigator agreement considerations
• Considerations for compliant documentation

Register here! 

Learn more about the conference here.

Within the past 2 years, interest in investigator-initiated clinical trials has increased greatly. The additional proof of practice and clinical application data that these types of trials provide have allowed for the transition of many newly approved therapies to standard practice.

While research offices are doing their best to support these endeavors, the additional administrative responsibilities involved are often unfamiliar, as they are normally taken on by industry sponsors and outside governmental agencies, including the new “final rule” requirements.

Join Velos and PFS Clinical for an informative, no-cost webinar on investigator-initiated trials and the "final rule" requirements on Thursday, September 14 at 12:00 PM CST. Besides getting tips and models for meeting requirements, learn how technology can help you develop protocols, observe compliance, and simplify submissions to clinicaltrials.gov.

Register here: anymeeting.com/PIID=ED52DE86844C38 

Join PFS Clinical For a Webinar on "Investigator Initiated Trials - Administrative Considerations for Successful Study Start-Up and Close Out". 

The main points covered in this webinar will be: 

1. How to articulate study status (interventional vs observational) during protocol development for correct billing and budgeting
2. Discuss strategies for partnering with industry funders in order to financially support IIT endeavors
3. Discuss recent changes to the Final Rule offering suggestions on how to implement compliant change

This webinar will be hosted by HCCA. Register here. 

One of the most important aspects of a clinical trial is a budget that adequately meets the financial needs of your institution; however, in the context of billing compliance, the process of building and negotiating a study budget can become complicated.

In this upcoming webinar, seasoned PFS Clinical staff Amanda Miller and Jill Surfus will review the basics of clinical trial budgeting, provide language tips to prevent potential compliance issues, and discuss how to incorporate a coverage analysis into the budgeting process. 

We hope you’ll join us for this complimentary webinar!

Billing compliance is a crucial aspect of any organization that conducts clinical trials. Nonetheless, understanding and applying reimbursement guidelines is one of the most challenging aspects of research. In addition to providing quality patient care, institutions have the added task of understanding and complying with all federal and state guidelines related to clinical research billing practices. These tasks are not only time consuming, but can lead to errors that are costly and could impact your organization’s Medicare standing. Join Senior Clinical Research Analysts Liz Christianson and Nicole Bruecker for a complimentary webinar during which you will learn:

• The basics of billing compliance and why it is necessary
• How to create a coverage analysis to achieve and document billing compliance
• The PI’s role in the billing compliance process

We hope you join us for this informative, no-cost presentation!

Within the past 2 years, interest in investigator-initiated clinical trials has increased greatly. The additional proof of practice and clinical application data that these types of trials provide have allowed for the transition of many newly approved therapies to standard practice. 

While research offices are doing their best to support these endeavors, the additional administrative responsibilities involved are often unfamiliar, as they are normally taken on by industry sponsors and outside governmental agencies. Consequently, mistakes made during the initial development and start-up stages of these trials are causing institutions significant financial and compliance-related ramifications. 

Join Clinical Research Analyst Liz Christianson as she discusses how to overcome these start-up struggles and oversights of investigator-initiated trials.

Register Here